These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4651773)

  • 41. [Effectiveness of paromomycin-I against Leishmania garnhami in heterozygote albino mice].
    Rezzano de Raffo S; Moreno G; García J; Scorza JV
    Rev Cubana Med Trop; 1985; 37(1):55-65. PubMed ID: 3915382
    [No Abstract]   [Full Text] [Related]  

  • 42. The distribution of free and non-ionic vesicular sodium stibogluconate in the dog.
    Collins M; Carter KC; Baillie AJ; O'Grady J
    J Drug Target; 1993; 1(2):133-42. PubMed ID: 8069551
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of in utero and lactational exposure to SbV on rat neurobehavioral development and fertility.
    Coelho DR; De-Carvalho RR; Rocha RC; Saint'Pierre TD; Paumgartten FJ
    Reprod Toxicol; 2014 Dec; 50():98-107. PubMed ID: 25461908
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antimony dextran complex in the treatment of leishmaniasis.
    SEN GUPTA PC; CHATTERJI A; MUKHERJEE AM
    J Indian Med Assoc; 1961 Dec; 37():585-90. PubMed ID: 13910615
    [No Abstract]   [Full Text] [Related]  

  • 45. Plasma antimony determination during cutaneous leishmaniasis treatment with intralesional infiltration of meglumine antimoniate.
    de Aguiar MG; Gonçalves JE; Souza MD; de Silva RE; Silveira JN; Cota G
    Trop Med Int Health; 2018 Oct; 23(10):1110-1117. PubMed ID: 30053341
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multivariate optimization of a method for antimony determination by hydride generation atomic fluorescence spectrometry in hair samples of patients undergoing chemotherapy against Leishmaniasis.
    Cardozo MC; Cavalcante DD; Silva DL; Santos WN; Bezerra MA
    An Acad Bras Cienc; 2016 Sep; 88(3):1179-90. PubMed ID: 27580363
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical efficacy and pharmacokinetics of antimony in cutaneous leishmaniasis patients treated with sodium stibogluconate.
    Zaghloul IY; Radwan MA; Al Jaser MH; Al Issa R
    J Clin Pharmacol; 2010 Nov; 50(11):1230-7. PubMed ID: 20663995
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Effect of heparin on absorption, distribution and excretion of chlortetracycline from the body of animals].
    Brodskiĭ EIa
    Antibiotiki; 1969 Apr; 14(4):365-7. PubMed ID: 5785936
    [No Abstract]   [Full Text] [Related]  

  • 49. Comparison as a lymphoscintigraphic agent between 99Tcm dextran and 99Tcm antimony sulphide colloid.
    Juma N; Andrey T; Ege GN
    Br J Radiol; 1985 Apr; 58(688):325-30. PubMed ID: 2415201
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Resorption, distribution and excretion after administration of 14C-labelled HB 419 in rabbits, rats and dogs].
    Kellner HM; Christ O; Rupp W; Heptner W
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1388+. PubMed ID: 5394459
    [No Abstract]   [Full Text] [Related]  

  • 51. [Rifampicin pharmacokinetics in rabbits].
    Shorin VA; Kunrat LA
    Antibiotiki; 1974 Nov; 19(11):978-81. PubMed ID: 4457058
    [No Abstract]   [Full Text] [Related]  

  • 52. Oral pentoxifylline and pentavalent antimony for treatment of leishmaniasis: promising but inconclusive evidence of superiority, compared with antimony monotherapy.
    Ojha RP; Cervantes D; Fischbach LA
    Clin Infect Dis; 2007 Oct; 45(8):1104; author reply 1005-6. PubMed ID: 17879933
    [No Abstract]   [Full Text] [Related]  

  • 53. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Experimental alteration of the metabolism of chlorcyclizine and the incidence of cleft palate in rats.
    Posner HS; Graves A; King CT; Wilk A
    J Pharmacol Exp Ther; 1967 Mar; 155(3):494-505. PubMed ID: 4381513
    [No Abstract]   [Full Text] [Related]  

  • 55. Dose dependency of the kinetics of dextrans in rats: effects of molecular weight.
    Mehvar R; Robinson MA; Reynolds JM
    J Pharm Sci; 1995 Jul; 84(7):815-8. PubMed ID: 7562429
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Availability, Toxicology and Medical Significance of Antimony.
    Periferakis A; Caruntu A; Periferakis AT; Scheau AE; Badarau IA; Caruntu C; Scheau C
    Int J Environ Res Public Health; 2022 Apr; 19(8):. PubMed ID: 35457536
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Toxicity and efficacy of the antileishmanial drug meglumine antimoniate in the owl monkey (Aotus trivirgatus).
    Chapman WL; Hanson WL; Hendricks LD
    J Parasitol; 1983 Dec; 69(6):1176-7. PubMed ID: 6674468
    [No Abstract]   [Full Text] [Related]  

  • 58. 99mTc-labelled compounds prepared with antimony (III) as reducing agent.
    Vilcek S; Machán V; Kalincák M
    Radiobiol Radiother (Berl); 1982; 23(3):333-8. PubMed ID: 6758027
    [No Abstract]   [Full Text] [Related]  

  • 59. [Effect on the organs and blood of experimental animals, body distribution and excretion of the antineoplastic antibiotic tauromycetin].
    Vertogradova TP; Kunrat IA; Muraveĭskaia VS
    Antibiotiki; 1970 Jan; 15(1):59-63. PubMed ID: 5442476
    [No Abstract]   [Full Text] [Related]  

  • 60. [Nature of the complex action of antimony trisulfide and its distribution in the body].
    Mel'nikova NN
    Gig Tr Prof Zabol; 1980 May; (5):51-2. PubMed ID: 7380319
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.